CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
Lab/Research institutions

地址:No.300,Yanling Middle Road, Changzhou, Jiangsu, China China (Mainland) Changzhou Jiangsu

主营产品:Rapamycin(53123-88-9),Bendazac L-lysine(81919-14-4),Leflunomide(75706-12-6),Xanthophyll(127-40-2),Probenecid(57-66-9)

主要市场:North America Eastern Europe Eastern Asia

业务范围:Rapamycin(53123-88-9),Tacrolimus(104987-11-3), Leflunomide(75706-12-6),Everolimus(159351-69-6), Pirfenidone(53179-13-8),Nafamostat Mesylate(82956-11-4),Hexadecylpyridinium Chloride Monohydrate(6004-24-6),α-Naphthoflavone(604-59-1)

注册资本: 500000

公司规模:11 - 50People

成立年份:1984

法人代表:Xiaxiankun

Steven Zhang

0086-519-888027890086-13961196887

SHININGPHARMA@HOTMAIL.COM

www.czyys.com

CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD., founded in 1984, engages in pharmaceutical research, development, production, process design and technical consultation of synthetic pharmaceutical products. The organizational structure includes RD Dept., Quality Inspection Dept., Pilot Plant and Sales Dept., etc. Our pilot plant established 100,000 grade asepsis drug preparation workshop, biological extraction workshop as well as rectification, drying and packaging workshops for synthetic drug. Our laboratory has advanced inspection facilities such as UV, GC, HPLC etc. and equipped with high-pressure reactors, high vacuum and high fractional distillation. Our products are exported to North American, European and Southeast Asian countries and the high quality of our products is positively recognized by our domestic and overseas clients.